A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-02-01
著者
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Komatsu H
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
MORI Yumiko
Department of Biotechnology, Graduate School of Engineering, Osaka University
-
Naoe Tomoki
名古屋大学 医学系研究科血液・腫瘍内科学
-
KIYOI Hitoshi
Nagoya University Hospital
-
MINAMI Yosuke
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Minami Yosuke
名古屋大学 医学系研究科血液・腫瘍内科学
-
Minami Yosuke
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kiyoi Hitoshi
豊橋市民病院 血液・腫瘍内科
-
Kosugi H
Department Of Hematology Ogaki Municipal Hospital
-
Kiyoi Hitoshi
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Ishikawa Yuichi
癌研有明病院 泌尿器科
-
Naoe Tomoki
Department Of Hematologly And Oncology Nagoya University School Of Medicine
-
Kosugi Hiroshi
Institute For Chemical Research Tohoku University
-
MIYATA Yasuhiko
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Miyata Yasuhiko
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kobayashi Miki
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kobayashi Miki
Department Of Applied Analysis And Complex Dynamical Systems Graduate School Of Informatics Kyoto Un
-
Ishikawa Yuichi
Faculty Of Bioresource Sciences Akita Prefectural University
-
Naruse T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Ishikawa Kazuhiro
Department Of Materials Science And Engineering Kitami Institute Of Technology
-
Suzuki Tatsuya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Suzuki Tatsuya
Department Of Chemistry And Biotechnology School Of Engineering The University Of Tokyo
-
Iriyama Chisako
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
SAKAI Katsuya
Faculty of Pharmacy, Meijo University
-
OZAWA Yukiyasu
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
KANEDA Norio
Faculty of Pharmacy, Meijo University
-
Kaneda Norio
Faculty Of Pharmacy Meijo University
-
Sakai Katsuya
Faculty Of Pharmacy Meijo University
-
Ozawa Yukiyasu
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Nakano Tatsunori
Second Departmant Of Medicine Nagoya City University Medical School
-
Ishikawa Kazuhiro
Department Of Infections Diseases Nagoya University School Of Medicine
-
Kobayashi Miki
Department of Agricultural Chemistry, Faculty of Agriculture, Kyoto University
関連論文
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- PE-406 Relation of Body Mass Index to the Recurrence of Atrial Fibrillation after Pulmonary Vein Isolation via Radio Frequency Catheter Ablation(Diabetes/Obesity/Metabolic syndrome(07)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the J
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Vagal Modification Can Also Help Prevent Late Recurrence of Atrial Fibrillation After Segmental Pulmonary Vein Isolation